References-
[1] Yang W, Cao Q, Qin L, Wang X, Cheng Z, Pan A, et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city, Zhejiang, China. J Infect. 2020;80:388–93.
[2] Sen M, Lahane S, Lahane TP, Parekh R, Honavar SG. Mucor in a viral land: A tale of two pathogens. Indian J Ophthalmol. 2021;69:244-52.
[3] Honavar SG. Code Mucor: Guidelines for the Diagnosis, Staging and Management of Rhino-Orbito-Cerebral Mucormycosis in the Setting of COVID-19. Indian J Ophthalmol. 2021;69:1361-5.
[4] Mathur S, Karimi A, Mafee MF. Acute optic nerve infarction demonstrated by diffusion-weighted imaging in a in a case of rhinocerebral mucormycosis. Am J Neuroradiol. 2007;28:489–90.
[5] Chae HK, Lim J, Lee SC, Kim KS. The Significance of ”Black Turbinate Sign” on MRI. Ear Nose Throat J. 2020;99:395-6.
[6] Joshi AR, Muthe MM, Patankar SH, Athawale A, Achhapalia Y. CT and MRI Findings of Invasive Mucormycosis in the Setting of COVID-19: Experience From A Single Center in India. AJR Am J Roentgenol. 2021 Jun 23. doi:10.2214/AJR.21.26205.
[7] Safder S, Carpenter JS, Roberts TD, Bailey N. The ”Black Turbinate” sign: An early MR imaging finding of nasal mucormycosis. AJNR Am J Neuroradiol. 2010;31:771-4.
[8] Mohindra S, Mohindra S, Gupta R, Bakshi J, Gupta SK. Rhinocerebral mucormycosis: the disease spectrum in 27 patients. Mycoses. 2007;50:290-6.
[9] Ferguson BJ. Mucormycosis of the nose and Paranasal sinuses. Otolaryngol Clin North Am. 2000;3:349-65.
[10] Gillespie MB, O’Malley BW. An algorithmic Approach to the diagnosis and management of invasive fungal rhinosinusitis in the immunocompromised patient. Otolaryngol Clin North Am 2000; 33:323-34.